Ovarian Squamous Cell Carcinoma
2 clinical trials · Condition
◉ Watch Ovarian Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Assessment of the Efficacy and Safety of Pembrolizumab for Ovarian Squamous Cell Carcinoma (NCT05737199) | Niigata University Medical & Dental Hospital | 2023-05-01 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
Track Ovarian Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.